Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mallinckrodt to spin off its speciality generics business next year

pharmaceutical-technologyDecember 10, 2018

Tag: Mallinckrodt , generics business , APIs , lubiprostone

PharmaSources Customer Service